Published: Mon, February 05, 2018
Health Care | By Alice Shelton

Heart disease/breast cancer link

Heart disease/breast cancer link

Older breast cancer patients more often die of heart disease than cancer. Previous research has shown that chemotherapy weakens the heart, but the AHA is concerned that the link to cancer drugs may be missed if cardiovascular symptoms are experienced years after treatment, according to the article.

Identifying at-risk patients is crucial.

The interconnection doesn't end when the cancer is gone.

Time and money allotted to breast cancer research have far outpaced the resources afforded to prostate cancer research, she said.

Women on those medications will have their heart function monitored during treatment. Delivery methods, such as doxorubicin as an intravenous infusion instead of a bolus dose, or liposomal formulations of doxorubicin compared to standard preparations, may preserve the efficacy of therapy while reducing the incidence of cardiotoxicity.

According to Mehta, women should pay attention to any potential heart disease symptoms such as breathlessness and chest pain - and then make sure they tell their doctor about their cancer treatment history.

In many ways, the AHA statement is trying to change the mindset of women diagnosed with breast cancer who consider it the biggest threat to their health. For their part, oncologists have said that the American cardiologists' announcement should not discourage women with breast cancer from doing more aggressive treatment if necessary.

But Prostate Cancer UK says the latest statistics should act as a wake-up call for anyone who still may have imagined that this disease is somehow minor, in demographic terms, compared to the ones we hear about all the time.

Valero Energy Corporation Will Attend The Raymond James Institutional Investors Conference
Following the sale, the chief financial officer now directly owns 309,119 shares of the company's stock, valued at $28,837,711.51. Media stories about Valero Energy (NYSE:VLO) have been trending somewhat positive on Friday, Accern Sentiment Analysis reports.

The anthracycline class of chemotherapeutic drugs can trigger abnormal heart rhythms, which may be benign or potentially life-threatening.

It is not the case that women do not treat cancer, but these treatments are done to minimize the risk to their hearts.

Among the chemotherapies used in breast cancer that may compromise cardiac function, doxorubicin - or Adriamycin - and trastuzumab, also known as Herceptin.

"However, the good news is that many of these developments could be applied to prostate cancer and we're confident that with the right funding, we can dramatically reduce deaths within the next decade".

In the USA and the United Kingdom, about 12% of women will develop breast cancer at some point in their lifetimes, according to the National Cancer Institute and the organization Cancer Research UK.

"The introduction of precision medicine, a screening program and a weighty research boost has no doubt played an important role in reducing the number of women who die from the disease", she said.

The AHA also continues to stress the importance of exercising, saying that breast cancer survivors can improve their chances of living a long, healthy life by exercising and eating well. "But there are side effects from these cancer treatments, and we're trying to recognize it in the very early phases so that we may be able to mitigate the heart effects and avoid significant heart damage".

Like this: